Adalimumab: a Treatment Option for Pyoderma Gangrenosum After Failure of Systemic Standard Therapies

BACKGROUND: Pyoderma gangrenosum (PG) belongs to a group of neutrophilic dermatoses and is often associated with systemic disorders. The authors present a patient with a recalcitrant PG that did not respond to systemic standard therapies, and discuss further treatment options with impact on quality...

Descripción completa

Detalles Bibliográficos
Autores principales: Hinterberger, Louisa, Müller, Cornelia S. L., Vogt, Thomas, Pföhler, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare Communications 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510423/
https://www.ncbi.nlm.nih.gov/pubmed/23205329
http://dx.doi.org/10.1007/s13555-012-0006-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510423/
https://www.ncbi.nlm.nih.gov/pubmed/23205329
http://dx.doi.org/10.1007/s13555-012-0006-6

Ejemplares similares